Associations between breast cancer and rheumatoid arthritis among older-age women in the United States

Clicks: 18
ID: 332409
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #191 of 407 articles by views in JNCI Journal of the National Cancer Institute

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 407 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
BACKGROUND: Several studies have described an inverse association between rheumatoid arthritis (RA) and risk of breast cancer (BC), and one study reported lower risk of RA after BC. Factors contributing to this possibly bidirectional relationship remain unclear. METHODS: Using the SEER-Medicare database (2008-2021), we conducted a case-control study to evaluate the association between RA and BC risk among women aged 66-99. RA was identified from Medicare claims. We also conducted a cohort study among BC cases and controls to evaluate subsequent RA incidence. Multivariable adjusted odds ratios (ORs) were estimated using generalized linear mixed models and hazard ratios (HRs) using Cox regression. RESULTS: We included 204,186 BC cases and 2,897,862 controls. RA was inversely associated with BC (OR 0.80, 95%CI 0.77-0.83)-specifically, for hormone receptor positive BC (0.78, 0.76-0.81). In the cohort analysis (184,524 women with and without BC), BC was associated with lower incidence of RA (HR 0.93, 95% CI 0.88-0.98). This association did not differ by BC hormone receptor status. Instead, among women with BC, radiotherapy was associated with reduced RA incidence (HR 0.82, 95%CI 0.76-0.89). Finally, among women with hormone receptor positive BC, treatment with exemestane was associated with increased incidence of RA (HR 1.33, 95%CI 1.17-1.50). CONCLUSION: These findings support a bidirectional inverse association between RA and BC. Hormone-related pathways may contribute to reduced BC risk in women with RA, whereas radiotherapy-related immune modulation may partly explain the lower incidence of RA incidence following BC. Further mechanistic studies are warranted.
Reference Key
openalex_W7221814477 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal JNCI Journal of the National Cancer Institute
Year 2026
DOI
10.1093/jnci/djag387
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.